Wnt-5a as a potential novel biomarker in myocardial infarction
- Authors: Snimshchikova I.A.1, Konshina A.V.2
-
Affiliations:
- I. Turgenev Orel State University
- N. Priorov National Medical Research Center of Traumatology and Orthopedics
- Issue: Vol 28, No 3 (2025)
- Pages: 817-822
- Section: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/1028-7221/article/view/319940
- DOI: https://doi.org/10.46235/1028-7221-17271-WAA
- ID: 319940
Cite item
Full Text
Abstract
Cardiovascular diseases are the leading cause of morbidity and mortality worldwide, thus emphasizing a need for innovative approaches to their diagnostics, prevention and treatment. One of the promising areas is a fundamental role of a highly conservative Wnt signaling pathway. Wnt-5a is a Wnt ligand secreted by various cells, involved in the embryogenesis, homeostasis and body regeneration. Due to multifunctional, potentially contradictory Wnt-5a effects, additional studies are required in order to better understand the molecular mechanisms of its involvement in pathogenesis of ischemic heart disease and to develop new diagnostic approaches using Wnt-5a as a promising biomarker. The purpose of the work was to study clinical significance of serum Wnt-5a level in acute myocardial infarction. The study included 70 young and middle-aged patients with acute myocardial infarction (Group I) admitted to the Orel Regional Clinical Hospital, and 20 healthy individuals (Group II, controls) matched for age and gender. Acute myocardial infarction (AMI) was diagnosed according to the clinical guidelines of the Russian Health Ministry. The level of Wnt-5a and IL-6 in the blood serum was determined in two replicates by enzyme-linked immunosorbent assay using Sunlong Biotech Co and Vector-Best reagent kits. Statistical calculations were performed in the StatTech online program. The study has shown that the median values of Wnt-5a were significantly lower in blood serum of AMI patients compared to healthy individuals. The lowest Wnt-5a values were observed on day 1 in patients with a history of myocardial infarction and extensive postinfarction cardiosclerosis, with a tendency for Wnt-5a increase by day 7, being associated with severe course of myocardial infarction. In patients with typical myocardial infarction, a decrement of Wnt-5a values was noted by day 7 of the pathological process. The maximum Wnt-5a values were recorded in patients with calcification of heart valves and coronary vessels. We have found an inverse correlation between Wnt-5a and IL-6 associated with inflammatory process in myocardial infarction. The obtained results suggest a value of Wnt-5a as a potential biomarker of acute myocardial infarction, requiring further reserach on its cardioprotective role aiming at development of novel diagnostic and therapeutic strategies.
Full Text
##article.viewOnOriginalSite##About the authors
I. A. Snimshchikova
I. Turgenev Orel State University
Author for correspondence.
Email: snimshikova@mail.ru
PhD, MD (Medicine), Professor, Head of the Department of Immunology and specialized clinical disciplines, Director of Medical Institute, Leading Researcher at the Laboratory of New Medical Technologies
Russian Federation, OrelA. V. Konshina
N. Priorov National Medical Research Center of Traumatology and Orthopedics
Email: snimshikova@mail.ru
PhD (Biology), Associate Professor of the Department of Traumatology, Orthopedics and Related Disciplines, Head of the Department of Educational Activities
Russian Federation, MoscowReferences
- Bansal A., Hiwale K. Updates in the management of coronary artery disease: a review article. Cureus, 2023, Vol. 15, no. 12, e50644. doi: 10.7759/cureus.50644.
- Bhatt P.M., Malgor R. Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis, 2014, Vol. 237, no. 1, pp. 155-162.
- Chen X., Liu H.L., Li D.H., Wang J.S., Zhao F. Dual role of Wnt5a in the progression of inflammatory diseases. Chin. Med. Sci. J., 2022, Vol. 37, no. 3, pp. 265-274.
- Fu W.B., Wang W.E., Zeng C.Y. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol. Sin., 2019, Vol. 40, no. 1, pp. 9-12.
- Halleskog C., Schulte G. WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia. J. Neurochem., 2013, Vol. 125, no. 6, pp. 803-808.
- Hayat R., Manzoor M., Hussain A. Wnt signaling pathway: A comprehensive review. Cell Biol. Int., 2022, Vol. 46, no. 6, pp. 863-877.
- Horitani K., Shiojima I. Wnt signaling in cardiac development and heart diseases. In Vitro Cell. Dev. Biol. Anim., 2024, Vol. 60, no. 5, pp. 482-488.
- Huang Y., Xue Q., Chang J., Wang X., Miao C. Wnt5a: A promising therapeutic target for inflammation, especially rheumatoid arthritis. Cytokine, 2023, Vol. 172, 156381. doi: 10.1016/j.cyto.2023.156381.
- Li D., Sun J., Zhong T.P. Wnt signaling in heart development and regeneration. Curr. Cardiol. Rep., 2022, Vol. 24, no. 10, pp. 1425-1438.
- Nedkoff L., Briffa T., Zemedikun D., Herrington S., Wright F.L. Global trends in atherosclerotic cardiovascular disease. Clin. Ther., 2023, Vol. 45, no. 11, pp. 1087-1091.
- Rim E.Y., Clevers H., Nusse R. The Wnt Pathway: from signaling mechanisms to synthetic modulators. Annu. Rev. Bioche., 2022, Vol. 91, pp. 571-598.
- Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., Bonny A., Brauer M., Brodmann M., Cahill T.J., Carapetis J., Catapano A.L., Chugh S.S., Cooper L.T., Coresh J., Criqui M., DeCleene N., Eagle K.A., Emmons-Bell S., Feigin V.L., Fernández-Solà J., Fowkes G., Gakidou E., Grundy S.M., He F.J., Howard G., Hu F., Inker L., Karthikeyan G., Kassebaum N., Koroshetz W., Lavie C., Lloyd-Jones D., Lu H.S., Mirijello A., Temesgen A.M., Mokdad A., Moran A.E., Muntner P., Narula J., Neal B., Ntsekhe M., de Oliveira G.M., Otto C., Owolabi M., Pratt M., Rajagopalan S., Reitsma M., Ribeiro A.L.P., Rigotti N., Rodgers A., Sable C., Shakil S., Sliwa-Hahnle K., Stark B., Sundström J., Timpel P., Tleyjeh I.M., Valgimigli M., Vos T., Whelton P.K., Yacoub M., Zuhlke L., Murray C., Fuster V.; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J. Am. Coll. Cardiol., 2020, Vol. 76, pp. 2982-3021.
- Snimshchikova I.A., Plotnikova M.O. Role of morphogenic proteins of the WNT signaling pathway in coronary artery disease. Medical Immunology (Russia), 2023, Vol. 25, no. 4, pp. 985-990. doi: 10.15789/1563-0625-ROM-2835.
- Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol., 2014, Vol. 6, no. 10, a016295. doi: 10.1101/cshperspect.a016295.
- van Dijk E.M., Menzen M.H., Spanjer A.I., Middag L.D., Brandsma C.A., Gosens R. Noncanonical WNT- 5B signaling induces inflammatory responses in human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol., 2016, Vol. 310, no. 11, pp. L1166-L1176.
Supplementary files
